REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

The First Transcatheter Mitral Valve Implantation Was Completed at Sheba Medical Center

First Transcatheter Mitral Valve Implantation
The new transcatheter mitral valve procedure offers a minimally invasive solution for mitral regurgitation

Mitral regurgitation is a common condition in which the heart’s mitral valve leaflets do not close tightly, usually resulting from infection or one of a few cardiovascular connective tissue diseases. When this happens, blood flows backward from the heart’s left ventricle into the left atrium. This forces the heart to work harder to push blood through the body, which can cause fatigue and shortness of breath.

Until recently, the only treatment available for mitral regurgitation was a conventional mitral valve replacement surgery, an invasive procedure with a long recovery period. After receiving a patient suffering from underlying conditions that pose an increased risk for conventional mitral valve replacement surgery, Sheba Medical Center, for the first time in Israel, has opted to perform a new breakthrough transcatheter mitral valve implantation.

The Tendyne Bioprosthetic Mitral Valve System is a novel minimally invasive procedure that offers select patients who suffer from symptomatic, significant mitral regurgitation a safe and effective valve replacement. The procedure involves a small incision in the chest between the ribs in order to gain catheter access to the heart apex.

The first transcatheter mitral valve implantation performed at Sheba was completed successfully, and the second successful implantation followed soon after.

“This innovative procedure allows us to offer patients, who until recently had no medical solution, a new hope with minimal risks,” said Prof. Israel Barabash, Director of the Catheterization Services at Sheba Medical Center.

Prof. Victor Guetta, Head of the Invasive Cardiology Unit, added: “For me, the essence of medicine is not settling for improving existing procedures, but developing new ways to treat patients with conditions that currently remain untreated.”

First Transcatheter Mitral Valve Implantation
Related
virtual care
Nuvo Group and Sheba Develop AI-Powered Gestational Diabetes Management Platform
A groundbreaking gestational diabetes pilot was recently completed by the two organizations, deploying Nuvo's INVU platform at Sheba’s Beyond Virtual Hospital, simplifying care for pregnant…
Read More
pain treatment for pancreatic cancer
Breakthrough Study: Radiation Therapy Effective for Pain Management in Cancer Patients
Pancreatic cancer, the 12th most common cancer worldwide, is associated with pain in approximately 75% of patients at the time of diagnosis, and as much…
Read More
arc center
News Nov 30.
Real-Time Detection of Cancerous Biomarkers With Artificial Intelligence
Lung cancer is the most common cancer and accounts for 1.76 million deaths per year worldwide. Non-small cell lung cancer (NSCLC) comprises 85% of all…
Read More